SAN FRANCISCO, CA
Allocation by class
Portfolio Concentration
Top 3 weight
79.2%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 21.96M
Full voting authority
0.00
shares
Joint voting authority
21.96M
shares
No voting authority
0.00
shares
Investment Discretion (by position count)
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Monte Rosa Therapeutics, Inc.OTR | Common Stock | 3.18M | SH | $76.97M 47.34% | 0.00 | 3.18M | 0.00 |
Century Therapeutics, Inc.OTR | Common Stock | 12.17M | SH | $29.81M 18.33% | 0.00 | 12.17M | 0.00 |
Jade Biosciences, Inc.OTR | Common Stock | 991.78K | SH | $22.04M 13.55% | 0.00 | 991.78K | 0.00 |
Lenz Therapeutics, Inc.OTR | Common Stock | 2.66M | SH | $15.09M 9.28% | 0.00 | 2.66M | 0.00 |
Contineum Therapeutics, Inc.OTR | Common Stock | 542.63K | SH | $8.89M 5.47% | 0.00 | 542.63K | 0.00 |
CRISPR Therapeutics AGOTR | Common Shares | 148.83K | SH | $8.12M 4.99% | 0.00 | 148.83K | 0.00 |
Skye Bioscience, Inc.OTR | Common Stock | 2.01M | SH | $1.39M 0.86% | 0.00 | 2.01M | 0.00 |
Tempest Therapeutics, Inc.OTR | Common Stock | 269.77K | SH | $299.4K 0.18% | 0.00 | 269.77K | 0.00 |